Enzymedica, Inc. is excited to announce that Dr. Michael Murray, author of over 30 books, including "The Encyclopedia of Natural Medicine," and an individual who has been recently named "The Voice of Natural Medicine" by Nutrition Business Journal, has joined the company as Chief Science Officer.

According to Scott Sensenbrenner, CEO, "Dr. Murray is a true icon in the natural health movement and brings tremendous credibility, experience, and passion to our company."

Dr. Murray will be critical to driving new innovations in product development for Enzymedica, as well as leading research efforts to create next generation formulas that will be groundbreaking for the industry.

In addition to his role with Enzymedica, Dr. Murray will be working closely with the Roskamp Institute in Sarasota, Fl. This non-profit organization is performing cutting edge research for organizations like the National Institutes of Health (NIH), Department of Defense (DOD) and the European Union (EU). Roskamp is renowned for their team's research on Alzheimer's disease, Gulf War Illness, and other complex diseases. Dr. Murray and the Institute will be developing better answers for improving brain health, the human microbiome and digestion.

Enzymedica's strategic relationship with the Roskamp Institute gives it the resources and expertise critical for providing innovative, science-based natural products, furthering its contribution to digestive health. This close partnership is further demonstrated by Sensenbrenner, who serves on the Board of Directors of the Roskamp Institute.

Dr. Murray says, "I am thrilled to be part of the team at both Enzymedica and the Roskamp Institute. It is a dream come true."

Sensenbrenner and Dr. Murray previously worked together in the 1990s at Enzymatic Therapy, which was later acquired by the German company Dr. Wilmarr Schwabe Pharmaceuticals.

For media requests in UK and Europe, please contact:
Susan Warris-Liepa
Phone: 0845 528 1296

Michael T. Murray, N.D.

About Enzymedica:
Florida-based Enzymedica, Inc. was founded in 1998 to offer consumers targeted enzyme products, and only uses the highest quality vegetarian enzyme sources available. Digest™ and Digest Gold™ are the two top-selling digestive enzymes in the U.S. market according to SPINS, a market research and consulting firm for the Natural Products Industry. Enzymedica is a proud supporter of many green initiatives, including use of solar energy, recycled steel for its building and recycled paper for packing and shipping. Enzymedica also sponsors Vitamin Angels and initiatives in autism.

About Dr. Murray:
Dr. Murray is one of the world's leading authorities on natural medicine. He has published over 30 books featuring natural approaches to health. He is a graduate, former faculty member, and serves on the Board of Regents of Bastyr University in Seattle, Washington.

Download as PDF| Report this press release


About Enzymedica UK

For over 20 years Enzymedica has been researching, creating and producing exclusive blends of plant-based digestive enzymes for digestive health and food intolerances. With exceptional quality and purity utilized at point of manufacture, Enzymedica is dedicated to providing enzyme-focused supplements at the most therapeutic levels available in the natural foods industry. Enzymedica’s unique, patented TheraBlend ™ and TherActive™ delivery technologies allow for up to 6 x faster absorption in the digestive system. All Enzymedica products provide immediate bioavailability, have absolutely no fillers, and are 100% vegetarian.

Enzymedica’s enzyme formulas lead the industry in quality and efficacy and have a line of award winning products that have been honoured by both retailers and consumers. Digest™ and Digest Gold™ are the two top selling digestive enzymes in the USA market place, according to SPINS, a market research and consulting firm for the Natural Products Industry. Enzymedica UK is fast gaining awards and recognition for the brand by consumers and independent health food store owners alike. The Janey Loves Platinum Award 2017 for Digest Gold is the latest UK consumer recognition for the excellence of the brand.

Enzymes do so much more than relieve the symptoms often associated with digestive distress such as heartburn, indigestion and bloating. They are the foundation to good health and have been called the “spark of life”. Enzymedica believes that knowledge has the power to change lives and is committed to providing education and research that propels individuals on the path to vibrant health. Digestive health questions will be answered by the Enzymedica team of health experts.

Dedicated to digestive health worldwide, Enzymedica provides financial support and educational outreach to the autism community and beyond. In 2009 Tom Bohager, Founder of Enzymedica, founded the Autism Hope Alliance (AHA), a non-profit organisation dedicated to raising funds for autism awareness and treatment.

TMC Ventures Europe Ltd. is proud to be the exclusive distributor for Enzymedica UK & Ireland. TMC Ventures is an importing and distribution company that focuses on innovative, interesting and differentiated products - making a healthy difference in the lives of their customers.

TMC Ventures provides a boutique management and consulting service to American Brands that wish to gain market presence in the UK and Europe.

More from Enzymedica UK